ALP Bio raises €161K from Venture Kick to improve the safety of biologic medicines

ALP Bio is developing an AI-powered platform that helps drug developers identify immune-related risks earlier in the development process, supporting the design of safer biologic medicines and advancing collaborations with pharmaceutical partners.

Raccontata datech.eu